Renal Protective Effect of Naringin in an LPS-Induced Acute Kidney Injury Model in Mice
DOI:
https://doi.org/10.36283/PJMD13-3/014Keywords:
Naringin, lipopolysaccharide, Sepsis, acute kidney injury, TLR-4 pathway, inflammationAbstract
Background: Acute kidney injury (AKI) is a severe consequence of sepsis, characterized by rapid onset and high mortality. Naringin has broad pharmacological effects; however, its role in AKI remains unclear. Here, we evaluated the protective effects of naringin against lipopolysaccharide (LPS)-induced AKI in mice.
Methods: This in-vivo pre-clinical experimental study was conducted at Ziauddin University, from March-October 2023. Using Simple Random sampling, 24 male BALB/c mice weighing between 25-30 grams were divided into 4 groups (n=6). Normal control group (A), received intraperitoneal (I.P.) normal saline; Disease group (B) received LPS (2mg/kg; I.P.); The naringin-treated groups (C&D) were subjected to I.P. naringin treatment at 50mg/kg and 100 mg/kg doses for 4 days followed by 2mg/kg LPS I.P. Serum creatinine and urea levels were measured using calorimetric assay and kidney histopathological changes by H&E & PAS. Using SPSS v.25, Shapiro-Wilk test was used for normality and ANOVA, and Tukey’s Post Hoc analysis was done for inter-group comparison.
Results: LPS induced elevation of serum creatinine and urea, but naringin treatment significantly reduced these (p=0.000 and p=0.026). LPS also increased tubular injury scores. Naringin significantly reduced LPS-induced Tubular injury (p=0.026). Group-C showed a significant difference from normal, indicating disease development. Conversely, the 100mg/kg group not only distanced itself from the disease but also approached normal levels showing that improvement is more pronounced in the 100mg/kg.
Conclusion: Naringin protects renal tubular cell morphology from LPS-induced damage. Due to this effect, it preserves the urea and creatinine clearance functions of these cells, ultimately preventing acute renal failure.
Keywords: Lipopolysaccharide (LPS), Inflammation, Acute Kidney Injury, Sepsis.
References
Zarbock A, Nadim MK, Pickkers P, Gomez H, Bell S, Joannidis M, et al. Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup. Nat Rev Nephrol. 2023;19(6):401–417. DOI 10.1038/s41581-023-00683-3
Chang YM, Chou YT, Kan WC, Shiao CC. Sepsis and Acute Kidney Injury: A Review Focusing on the Bidirectional Interplay. International Journal of Molecular Sciences. 2022;23(16):9159. DOI 10.3390/ijms23169159
Yang S, Su T, Huang L, Feng LH, Liao T. A novel risk-predicted nomogram for sepsis associated-acute kidney injury among critically ill patients. BMC Nephrol. 2021;22(1):173. DOI 10.1186/s12882-021-02379-x
Nesovic Ostojic J, Ivanov M, Mihailovic-Stanojevic N, Karanovic D, Kovacevic S, Brkic P, et al. Hyperbaric Oxygen Preconditioning Upregulates Heme OxyGenase-1 and Anti-Apoptotic Bcl-2 Protein Expression in Spontaneously Hypertensive Rats with Induced Postischemic Acute Kidney Injury. International Journal of Molecular Sciences. 2021;22(3):1382. DOI 10.3390/ijms22031382
Font MD, Thyagarajan B, Khanna AK. Sepsis and Septic Shock – Basics of diagnosis, pathophysiology and clinical decision making. Medical Clinics. 2020;104(4):573–585. DOI 10.1016/j.mcna.2020.02.011
Aslan A, van den Heuvel MC, Stegeman CA, Popa ER, Leliveld AM, Molema G, et al. Kidney histopathology in lethal human sepsis. Crit Care. 2018;22(1):359. DOI 10.1186/s13054-018-2287-3
Shu B, Feng Y, Gui Y, Lu Q, Wei W, Xue X, et al. Blockade of CD38 diminishes lipopolysaccharide-induced macrophage classical activation and acute kidney injury involving NF-κB signaling suppression. Cellular Signalling. 2018;42: 249–258. DOI: 10.1016/j.cpem.2014.04.005
Ban KY, Nam GY, Kim D, Oh YS, Jun HS. Prevention of LPS-Induced Acute Kidney Injury in Mice by Bavachin and Its Potential Mechanisms. Antioxidants. 2022;11(11):2096. DOI: 10.3390/antiox11112096
Markwart R, Saito H, Harder T, Tomczyk S, Cassini A, Fleischmann-Struzek C, et al. Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1536–1551. DOI:10.1007/s00134-020-06106-2
Ma S, Evans RG, Iguchi N, Tare M, Parkington HC, Bellomo R, et al. Sepsis-induced acute kidney injury: A disease of the microcirculation. Microcirculation. 2019;26(2):e12483. DOI:10.1111/micc.12483
Meersch M, Volmering S, Zarbock A. Prevention of acute kidney injury. Best Practice & Research Clinical Anaesthesiology. 2017;31(3):361-370.DOI 10.1016/j.bpa.2017.08.002
Doyle JF, Forni LG. Update on sepsis-associated acute kidney injury: emerging targeted therapies. Biologics: Targets and Therapy. 2016;10:149–156. DOI:10.2147/BTT.S87385
Li J, Zhang Z, Wang L, Jiang L, Qin Z, Zhao Y, et al. Maresin 1 Attenuates Lipopolysaccharide-Induced Acute Kidney Injury via Inhibiting NOX4/ROS/NF-κB Pathway. Front Pharmacol. 2021;12.
Kim JY, Hong HL, Kim GM, Leem J, Kwon HH. Protective Effects of Carnosic Acid on Lipopolysaccharide-Induced Acute Kidney Injury in Mice. Molecules. 2021;26(24):7589.
Yang T, Feng X, Zhao Y, Zhang H, Cui H, Wei M, et al. Dexmedetomidine Enhances Autophagy via α2-AR/AMPK/mTOR Pathway to Inhibit the Activation of NLRP3 Inflammasome and Subsequently Alleviates Lipopolysaccharide-Induced Acute Kidney Injury. Front Pharmacol. 2020;11.
Raja Kumar S, Mohd Ramli ES, Abdul Nasir NA, Ismail NHM, Mohd Fahami NA. Preventive Effect of Naringin on Metabolic Syndrome and Its Mechanism of Action: A Systematic Review. Evidence-Based Complementary and Alternative Medicine. 2019;2019: e9752826. DOI: 10.1155/2019/9752826
Charan J, Biswas T. How to calculate sample size for different study designs in medical research?. Indian journal of psychological medicine. 2013;35(2): 121-126.DOI 10.4103/0253-7176.116232
Lim J, Lee YY, Choy YB, Park W, Park CG. Sepsis diagnosis and treatment using nanomaterials. Biomedical Engineering Letters. 2021; 11:197-210. DOI 10.1007/s13534-021-00200-0
Gómez H, Kellum JA. Chapter 90 - Sepsis-Induced Acute Kidney Injury. In: Ronco C, Bellomo R, Kellum JA, Ricci Z, editors. Critical Care Nephrology (Third Edition). Philadelphia: Elsevier; 2019. p. 524-533.e3.
Peerapornratana S, Manrique-Caballero CL, Gómez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney International. 2019;96(5):1083–1099. DOI: 10.1016/j.kint.2019.05.026
Qizalbash L, Cleghorn S, McAlister L. Kidney Diseases. Clinical Paediatric Dietetics. 2020:238-286. DOI 10.1002/9781119467205.ch13
Tan RZ, Wang C, Deng C, Zhong X, Yan Y, Luo Y, et al. Quercetin protects against cisplatin-induced acute kidney injury by inhibiting Mincle/Syk/NF-κB signaling maintained macrophage inflammation. Phytotherapy Research. 2020;34(1):139–152. DOI:10.1002/ptr.6507
Cui Y, Gao H, Han S, Yuan R, He J, Zhuo Y, Feng YL, Tang M, Feng J, Yang S. Oleuropein attenuates lipopolysaccharide-induced acute kidney injury in vitro and in vivo by regulating toll-like receptor 4 dimerization. Frontiers in pharmacology. 2021; 12:617314. DOI 10.3389/fphar.2021.617314
Stabrauskiene J, Kopustinskiene DM, Lazauskas R, Bernatoniene J. Naringin and Naringenin: Their Mechanisms of Action and the Potential Anticancer Activities. Biomedicines. 2022;10(7):1686. DOI:10.3390/biomedicines10071686
Huang QL, Huang LN, Zhao GY, Liu C, Pan XY, Li ZR, Jing XH, Qiu ZY, Xin RH. Naringin attenuates Actinobacillus pleuropneumoniae-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway. BMC Veterinary Research. 2024;20(1):204. DOI 10.1186/s12917-024-04055-2
Fadholly A, Ansori AN, Sucipto TH. An overview of naringin: Potential anticancer compound of citrus fruits. Research Journal of Pharmacy and Technology. 2020;13(11):5613-5619. DOI 10.5958/0974-360X.2020.00979.8
Kim JY, Leem J, Hong HL. Melittin ameliorates endotoxin‐induced acute kidney injury by inhibiting inflammation, oxidative stress, and cell death in mice. Oxidative medicine and cellular longevity. 2021;2021(1): 8843051. DOI 10.1155/2021/8843051
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
How to Cite
